Changes in the intestinal microflora of children with Helicobacter pylori infection and after Helicobacter pylori eradication therapy
Lou, J-gan.; Chen, J.; Huang, X-lei.; Zhao, Z-yan.
Chinese Medical Journal 120(10): 929-931
2007
ISSN/ISBN: 0366-6999 PMID: 17543185 Document Number: 614076
Document emailed within 1 workday
Related Documents
Zerbib, F. 1998: Helicobacter pylori et anti-inflammatoires non stéroïdiens Helicobacter pylori et reflux gastro-œsophagien - Helicobacter pylori and NSAID. Helicobacter pylori in GORD Hepato-Gastro (Montrouge) 5(FEV): 56-60Koizumi, W.; Tanabe, S.; Imaizumi, H.; Hibi, K-ichi.; Kida, M.; Ohida, M.; Okayasu, I.; Saigenji, K. 2003: Effect of anti-Helicobacter pylori IgG antibody titer following eradication of Helicobacter pylori infection Hepato-Gastroenterology 50(49): 293-296
Kowalski, M. 2001: Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. the detection of H. pylori specific DNA in human coronary atherosclerotic plaque Journal of Physiology and Pharmacology An Official Journal of the Polish Physiological Society 52(1 Suppl 1): 3-31
Shimamoto, C.; Tokioka, S.; Hirata, I.; Tani, H.; Ohishi, H.; Katsu, K-ichi. 2002: Inhibition of Helicobacter pylori infection by orally administered yolk-derived anti-Helicobacter pylori antibody Hepato-Gastroenterology 49(45): 709-714
Vázquez Romero, M.; Boixeda de Miquel, D.; Valer López-Fando, M.P.; Albéniz Arbizu, E.; González Alonso, R.; Bermejo San José, F. 2003: Intestinal metaplasia: evolution after Helicobacter pylori eradication and influence in the success of eradicating therapy Revista Espanola de Enfermedades Digestivas: Organo Oficial de la Sociedad Espanola de Patologia Digestiva 95(11): 781
Fradkin, A.; Yahav, Y.; Diver-Haber, A.; Weisselberg, B.; Jonas, A. 1997: The value of anti-Helicobacter pylori IgG antibodies in establishing eradication of infection in children Israel Journal of Medical Sciences 33(2): 87-92
Romero Gómez, M.; Martínez Delgado, C.; Grande, L.; Otero Fernández, M.A.; Vargas, J.; Castro Fernández, M. 2000: Intravenous eradication therapy for bleeding gastroduodenal ulcer associated with Helicobacter pylori infection Revista Espanola de Enfermedades Digestivas: Organo Oficial de la Sociedad Espanola de Patologia Digestiva 92(6): 386-391
Uthaisaengsook, W. 2003: Low dose, one-week triple therapy (lanzoprazole, amoxycillin, clarithromycin) for eradication of Helicobacter pylori infection Journal of the Medical Association of Thailand 86(7): 599-602
Brzozowski, T.; Konturek, P.C.; Kwiecien, S.; Konturek, S.J.; Pajdo, R.; Drozdowicz, D.; Ptak, A.; Pawlik, M.; Stachura, J.; Pawlik, W.W.; Hahn, E.G. 2003: Triple eradication therapy counteracts functional impairment associated with Helicobacter pylori infection in Mongolian gerbils Journal of Physiology and Pharmacology: An Official Journal of the Polish Physiological Society 54(1): 33-51
Ciok, J.; Dzieniszewski, J.; Lucer, C. 1997: Helicobacter pylori eradication and antral intestinal metaplasia--two years follow-up study Journal of Physiology and Pharmacology: An Official Journal of the Polish Physiological Society 48(Suppl 4): 115-122
Ierardi, E.; Francavilla, R.; Panella, C. 1997: Effect of Helicobacter pylori eradication on intestinal metaplasia and gastric epithelium proliferation Italian Journal of Gastroenterology and Hepatology 29(5): 470-475
Gaidar, I.A.; Stepanova, E.V.; Mosiichuk, L.N.; Demeshkina, L.V.; Sheikhetova, G.A.; Bespalova, E.V.; Kudriavtseva, V.E.; Vcherashniaia, N.N. 2001: Particular features of the relationship of Helicobacter pylori and G cells in patients with duodenal ulcer, with special reference to the Helicobacter pylori strain Likars'ka Sprava 2001(4): 176-177
Maciorkowska, E.; Kaczmarski, M.; Kondej-Muszyńska, K.; Kemona, A.; Kowalczuk, J.ła.; Musaibili, S. 2004: Clinical picture and morphological changes of upper intestinal tract mucosa in children with Helicobacter pylori infection Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 17(100): 311-315
Shimizu, N.; Kubota, K.; Kaminishi, M. 2005: Eradication therapy for the remnant stomach infected with Helicobacter pylori Nihon Rinsho. Japanese Journal of Clinical Medicine 63(Suppl 11): 478-481
Eremina, E.Iu.; Bondarenko, V.M.; Zvereva, S.I.; Nikitina, O.I.; Shaposhnikova, L.I. 2008: Dysbiotic manifestations during eradication therapy of Helicobacter pylori and their corrections Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 2008(3): 62-66
Satoh, K. 2009: Second-line therapy for patients with Helicobacter pylori eradication failure Nihon Rinsho. Japanese Journal of Clinical Medicine 67(12): 2297-2302
Ren, Q.; Ma, B.; Yang, K.; Yan, X. 2010: Lafutidine-based triple therapy for Helicobacter pylori eradication Hepato-Gastroenterology 57: 102-103
Satoh, K.; Sugano, K. 2009: Helicobacter pylori eradication therapy for peptic ulcer disease Nihon Rinsho. Japanese Journal of Clinical Medicine 67(12): 2322-2326
Blum, A.L.; Kreiss, C.; Armstrong, D. 1995: Functional dyspepsia: approaches to Helicobacter pylori eradication therapy Leber Magen Darm 25(3): 112-116; 119-120
Parzecka, M.; Szaflarska-Popławska, A.; Mierzwa, G.; Gorzkiewicz, M.; Łuczak, S.; Grzybowski, T. 2009: Genetic type of Helicobacter pylori and the efficacy of eradication therapy Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 26(152): 105-109